The popularity of Viagra initially drove a boom for major pharmaceutical companies, however recent developments present a complicated scenario for investors. Off-patent competitors are reducing earnings, and ongoing https://arunlkgp160044.myparisblog.com/41726801/the-blue-pill-and-pharma-a-precarious-play